Vaccine anaphylaxis and Canadian public health policy.

Abrams, Elissa M; Zafack, Joseline G; Ismail, Shainoor J; Bettinger, Julie A; Hildebrand, Kyla J; Tunis, Matthew C

Abrams, Elissa M; Zafack, Joseline G; Ismail, Shainoor J; Bettinger, Julie A; Hildebrand, Kyla J; Tunis, Matthew C.

Afiliação

Abrams EM; Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, ON, K1A 0K9, Canada; Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MB, Canada. Electronic address: elissa.abrams@phac-aspc.gc.ca.
Zafack JG; Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, ON, K1A 0K9, Canada.
Ismail SJ; Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, ON, K1A 0K9, Canada; Metro City Medical Clinic, Edmonton, AB, Canada.
Bettinger JA; Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
Hildebrand KJ; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada.
Tunis MC; Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, ON, K1A 0K9, Canada.

Lancet Respir Med ; 11(4): 306-308, 2023 04.

Article em En | MEDLINE | ID: mdl-37000715

Assuntos

Anafilaxia; Vacinas; Humanos; Anafilaxia/prevenção & controle; Canadá/epidemiologia; Política Pública; Política de Saúde

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Anafilaxia Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google